Amyloid-β vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid
- 9 February 2007
- journal article
- Published by Elsevier in Neuroscience
- Vol. 144 (3), 950-960
- https://doi.org/10.1016/j.neuroscience.2006.10.020
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Dynamic regulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216: Implications for chronic treatments of neurodegenerative diseasesNeurobiology of Disease, 2005
- Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic miceBrain, 2005
- Exacerbation of Cerebral Amyloid Angiopathy-Associated Microhemorrhage in Amyloid Precursor Protein Transgenic Mice by Immunotherapy Is Dependent on Antibody Recognition of Deposited Forms of Amyloid βJournal of Neuroscience, 2005
- Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic miceExperimental Neurology, 2004
- Species-specific immune response to immunization with human versus rodent Aβ peptideNeurobiology of Aging, 2004
- Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administrationNeurobiology of Disease, 2003
- Immune responses against Aβ1–42 in HLA class II transgenic mice: implications for Aβ1–42 immune-mediated therapiesNeurobiology of Aging, 2003
- Cerebral Hemorrhage After Passive Anti-Aβ ImmunotherapyScience, 2002
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1Nature, 1996